Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119182 · ClinicalTrials.gov registry record
Transforming Research and Clinical Knowledge in Traumatic Brain Injury
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 2,996
- Enrollment target
NCT02119182: Completed study, sponsored by University of California, San Francisco.
NCT02119182 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 2,996 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02119182 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 2,996 participants
- Enrollment target
Study Summary
The overall goal of Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study is to determine the relationships among the clinical, neuroimaging, cognitive, genetic and proteomic biomarker characteristics for the entire spectrum of TBI from concussion to coma. TRACK-TBI will validate biomarkers and outcome measures for clinical trials, advance diagnostic and prognostic models for TBI and improve clinical trial design. The Investigators are enrolling patients within 24 hours of injury who present to a TRACK-TBI site with a brain injury that meets ACRM criteria and receives a clinically indicated head CT.
Primary Outcome
The Glasgow Outcome Scale - Extended (GOS-E) is the current gold standard of outcome for TBI.
Interventions
- BEHAVIORAL In-Person Outcome Assessment
- PROCEDURE 3T Magnetic Resonance Imaging (MRI)
- BEHAVIORAL Phone Outcome Assessment
- PROCEDURE Blood Draw for Plasma, DNA, Serum, RNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,996 participants |
| Start Date | 2014-03-02 |
| Est. Completion | 2020-08-31 |
What the finished NCT02119182 record still lists
NCT02119182 is an observational study that tracks outcomes without assigning an intervention. Its 2,996 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which In-Person Outcome Assessment is the first listed.
NCT02119182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02119182 about?
NCT02119182 is a clinical study titled "Transforming Research and Clinical Knowledge in Traumatic Brain Injury". The overall goal of Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study is to determine the relationships among the clinical, neuroimaging, cognitive, genetic and proteomic biomarker characteristics for the entire spectrum of TBI from concussion to coma. TRACK-TB...
What is the current status of trial NCT02119182?
This trial is currently completed. The enrollment target is 2,996 participants. The study started on 2014-03-02. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT02119182?
The interventions under investigation include: In-Person Outcome Assessment (BEHAVIORAL), 3T Magnetic Resonance Imaging (MRI) (PROCEDURE), Phone Outcome Assessment (BEHAVIORAL), Blood Draw for Plasma, DNA, Serum, RNA (PROCEDURE).
Who is sponsoring clinical trial NCT02119182?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05297734 · 2,996 participants · NA
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- NCT03860883 · 2,998 participants · NA
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI